E. Desmedt

Cerebrospinal fluid concentrations of vemurafenib in patients treated for brain metastatic BRAF-V600 mutated melanoma

L. Sakji-Dupré, Émilie Le Rhun, C. Templier et al. · Melanoma Research · 2015 · 61 citations

Pharmacotherapy, Anti-braf Agents, Neuro-oncology +20

Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil

V. Florin, E. Desmedt, S. Vercambre‐Darras et al. · Investigational New Drugs · 2011 · 61 citations

Cutaneous Metastases, Medicine, Melanoma +8

Oral metronomic cyclophosphamide in elderly with metastatic melanoma

Estelle Borne, E. Desmedt, Alain Duhamel et al. · Investigational New Drugs · 2009 · 36 citations

Medicine, Melanoma, Metronomic Therapy +6

Leptomeningeal metastasis in melanoma: a prospective clinical study of nine patients.

E. Pape, E. Desmedt, Fahed Zaïri et al. · PubMed · 2013 · 31 citations

BRAF inhibitor discontinuation and rechallenge in advanced melanoma patients with a complete initial treatment response

Céline Desvignes, Henry Abi Rached, C. Templier et al. · Melanoma Research · 2017 · 28 citations

Surgical Oncology, Brafi Therapy, Skin Cancer +13